Company
RiverVest Venture Partners
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Wugen | Funding | 2025-08-28 | |
| Biolinq | Series C | 2025-04-23 | |
| Glycomine | Series C | 2025-04-16 | |
| Atalanta Therapeutics | Series B | 2025-01-28 | |
| Alleviant Medical | Financing | 2025-01-15 | |
| InterVene | Series A Funding | 2024-10-08 | Lead |
| Bluejay Therapeutics | series c | 2024-05-09 | |
| Biolinq | Funding | 2024-04-04 | |
| Engrail Therapeutics | Series B Financing | 2024-03-19 | |
| Alleviant Medical | Equity funding | 2023-01-27 | Lead |